Health of the Nation Outcome Scales for Infants field trial: concurrent validity

Peter Brann1, Gordana Culjak2, Nick Kowalenko3

  • 1Eastern Health Child Youth Mental Health Service and Adjunct Lecturer Monash University, Australia.

Bjpsych Open
|July 12, 2021
PubMed

Insights

The Health of the Nation Outcome Scales for Infants (HoNOSI) demonstrates strong concurrent validity and internal consistency, meeting standards for infant mental health assessment. This clinician-reported tool is crucial for routine outcome measurement in young children.

Area of Science:

  • Child and Adolescent Mental Health
  • Psychometric Instrument Development
  • Infant Mental Health

Background:

  • Identified gap in routine outcome measures for social, emotional, and behavioral domains in infants and pre-schoolers.
  • Developed the Health of the Nation Outcome Scales for Infants (HoNOSI), a clinician-reported measure for infants aged 0-47 months.
  • Prior face validity testing indicated HoNOSI's utility in assessing mental health outcomes.

Purpose of the Study:

  • To examine the concurrent validity of the HoNOSI.
  • To assess the reliability and acceptability of HoNOSI using established criteria.

Main Methods:

  • Clinicians rated the mental health status of 108 infants using HoNOSI, Parent-Infant Relationship Global Assessment Scale (PIR-GAS), and symptom/distress measures.
  • Minimum of 26 clinicians participated in rating each infant's mental health status.
  • Evaluated instrument acceptability using COsensus-based Standards for the selection of health Measurement INstruments (COSMIN) criteria.

Main Results:

  • HoNOSI showed statistically significant correlations with PIR-GAS (rs = -0.73), Clinical Worry (rs = 0.77), and Severity Judgement (rs = 0.85) (P < 0.001).
  • Good internal consistency was observed for the HoNOSI.
  • HoNOSI met COSMIN criteria for concurrent validity and internal consistency.

Conclusions:

  • Confirmed a clear need for a routine outcome measure for infants.
  • Provided positive evidence for HoNOSI's validity and internal consistency.
  • Supported controlled release of HoNOSI with ongoing research and development.
Abstract

Related Concept Videos